IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.97B
1-Year Est. Return
106.57%
This Fund
S&P 500
1 Year Est. Return
+106.57%
AUM
$1.37B
AUM Growth
+$301M
(+28%)
Holding
90
Top Buys
| 1 | +$17.8M | |
| 2 | +$16.5M | |
| 3 | +$12.7M | |
| 4 |
Centene
CNC
|
+$12.1M |
| 5 |
Intuitive Surgical
ISRG
|
+$12M |
Top Sells
| 1 | +$26M | |
| 2 | +$25.9M | |
| 3 | +$17.5M | |
| 4 |
GE HealthCare
GEHC
|
+$14.8M |
| 5 |
Encompass Health
EHC
|
+$14.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$31B
| $230M | 16.8% |
1,600,000
|
|
||
2
Cytokinetics
CYTK
$7.85B
| $76.9M | 5.61% |
1,400,000
+400,000
|
|
||
3
Tenet Healthcare
THC
$20.6B
| $60.9M | 4.44% |
300,000
+25,000
|
|
||
4
Mineralys Therapeutics
MLYS
$2.25B
| $56.9M | 4.15% |
1,500,000
-1,200,000
|
|
||
5
Vera Therapeutics
VERA
$2.87B
| $49.4M | 3.6% |
1,700,000
+550,000
|
|
||
6
uniQure
QURE
$1.14B
| $35M | 2.55% |
600,000
-750,000
|
|
||
7
BrightSpring Health Services
BTSG
$8B
| $34M | 2.48% |
1,150,000
-100,000
|
|
||
8
Boston Scientific
BSX
$104B
| $29.3M | 2.14% |
300,000
-250,000
|
|
||
9
Regeneron Pharmaceuticals
REGN
$81.6B
| $28.1M | 2.05% |
50,000
|
|
||
10
Alignment Healthcare
ALHC
$3.7B
| $27.9M | 2.04% |
1,600,000
+1,200,000
|
|
||
11
Alnylam Pharmaceuticals
ALNY
$42.8B
| $27.4M | 1.99% |
60,000
+5,000
|
|
||
12
Novartis
NVS
$308B
| $25.6M | 1.87% |
200,000
|
|
||
|
13
Encompass Health
EHC
$10.7B
| $25.4M | 1.85% |
200,000
-120,000
|
|
||
14
Edgewise Therapeutics
EWTX
$3.14B
| $24.3M | 1.77% |
1,500,000
+500,000
|
|
||
15
AstraZeneca
AZN
$302B
| $23M | 1.68% |
300,000
+100,000
|
|
||
16
RadNet
RDNT
$4.71B
| $22.9M | 1.67% |
300,000
-100,000
|
|
||
17
Rhythm Pharmaceuticals
RYTM
$6.35B
| $22.2M | 1.62% |
220,000
+100,000
|
|
||
18
Neurocrine Biosciences
NBIX
$13B
| $21.1M | 1.53% |
150,000
|
|
||
19
Cardinal Health
CAH
$51.1B
| $20.4M | 1.49% |
130,000
-10,000
|
|
||
20
Rezolute
RZLT
$307M
| $18.8M | 1.37% |
2,000,000
+200,000
|
|
||
21
Revolution Medicines
RVMD
$19.6B
| $18.7M | 1.36% |
400,000
+75,000
|
|
||
22
Quest Diagnostics
DGX
$22.1B
| $16.2M | 1.18% |
85,000
-65,000
|
|
||
23
Elevance Health
ELV
$62.4B
| $16.2M | 1.18% |
50,000
-10,000
|
|
||
24
Elanco Animal Health
ELAN
$11.8B
| $16.1M | 1.17% |
800,000
+450,000
|
|
||
25
Edwards Lifesciences
EW
$49.8B
| $15.6M | 1.13% |
200,000
|
|